Literature DB >> 2872556

Factor VIII degradation products in heated concentrates.

T W Barrowcliffe, S J Edwards, G Kemball-Cook, D P Thomas.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 2872556     DOI： 10.1016/s0140-6736(86)91599-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  The infectious complications of blood transfusion.

Authors:  N A Buskard
Journal:  Can Fam Physician       Date:  1987-05       Impact factor: 3.275

2.  Pharmacokinetics of factor VIII in humans. Obtaining clinically relevant data from comparative studies.

Authors:  S Björkman; M Carlsson; E Berntorp; P Stenberg
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

3.  In vivo recovery and half-life time of a steam-treated factor IX concentrate in hemophilia B patients. The influence of reagents and standards.

Authors:  M Köhler; E Seifried; P Hellstern; G Pindur; C Miyashita; S Mörsdorf; F Fasco; E Wenzel
Journal:  Blut       Date:  1988-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.